A phase Ib study of ADI-PEG 20 plus pembrolizumab in advanced solid cancers.
Sign Up to like & getrecommendations! Published in 2018 at "Journal of Clinical Oncology"
DOI: 10.1200/jco.2018.36.15_suppl.2556
Abstract: 2556Background: Arginine deprivation with pegylated arginine deiminase (ADI-PEG 20) has been shown to upregulate tumor programmed death-ligand 1 (PD-L1) expression and T cell infiltration. Current ... read more here.
Keywords: peg plus; plus pembrolizumab; study adi; phase study ... See more keywords